The latest microcontrollers featuring field-oriented control bring higher efficiency to motor-control circuit designs in consumer ...
WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of ...
By “relevant PLLs,” we mean those PLLs comprising the synthesizer that significantly influence the operating band phase noise. For multiple PLL systems, this usually is the output PLL, which is ...
After only 28 days of treatment with ARCT-032 (10 mg), 4 out of 6 Class I CF participants exhibited encouraging reduction of mucus plug number and mucus volume 12-week study enrolling up to 20 CF ...
SEGGER introduces embedded software, Flasher BitStreamer, that further expands the programming capabilities of its ...
Over on YouTube [CuriousMarc] and [TubeTimeUS] team up for a multi-part series E&L MMD-1 Mini-Micro Designer Restoration. The ...
Neuphoria Therapeutics’ lead candidate has failed to improve social anxiety symptoms in a late-stage trial, prompting the biotech to discontinue the program and launch a strategic review of its ...
Terns Pharmaceuticals has shelved its oral GLP-1 obesity candidate after a phase 2 trial delivered a mix of weight loss and tolerability data that fell short of expectations as well as evidence the ...
Moderna, Inc. (NASDAQ:MRNA) revealed topline results on Wednesday from a Phase 3 trial evaluating the efficacy of mRNA-1647, the company’s investigational cytomegalovirus (CMV) vaccine. CMV is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback